Article Details
Retrieved on: 2023-01-09 23:35:36
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
JERUSALEM (Reuters) -The Omicron-adapted COVID-19 vaccine booster developed by Pfizer Inc and BioNTech SE sharply reduced hospitalizations among ...
Article found on: kfgo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here